1. Introduction
===============

Benign biliary stricture (BBS) is rare and most cases are caused by iatrogenic biliary injury, mainly after open or laparoscopic cholecystectomy, with reported occurrence in 0.1% to 0.5% of open procedures and 0.25% to 1.0% of laparoscopic surgeries.^\[[@R1],[@R2]\]^ The second most common cause is fibrosis at the site of surgical anastomosis after liver transplantation. Other conditions that can lead to benign bile duct obstruction include chronic pancreatitis, sclerosing cholangitis, cholelithiasis, sphincterotomy, and infection of the biliary tract.^\[[@R3]\]^ The clinical symptoms present as obstructive jaundice, chronic cholestasis, and cholangitis, as well as secondary biliary cirrhosis.^\[[@R4]\]^

Endoscopic treatment rather than percutaneous transhepatic biliary drainage or surgery is considered first-line treatment for BBS. Use of multiple plastic stents (MPS) has been recommended by the European Society of Gastrointestinal Endoscopy for BBS, and uncovered self-expandable metallic stents are not recommended because of removal problems caused by embedding.^\[[@R3],[@R5]\]^ Hence, covered self-expanding metallic stents (cSEMS) are an intriguing option for treatment of BBS due to their removability.

Because they are usually fibrotic and associated with a dilated bile duct, most benign strictures cannot be fully dilated during initial endoscopic retrograde cholangiopancreatography (ERCP). An average of 3 to 4 ERCP procedures are required to dilate, deploy stents, up-size, and ultimately remove all stents once the stricture has resolved. Placement of 10-mm single cSEMS results in radial dilation of a stricture equivalent to that of six or seven 10-Fr plastic stents.^\[[@R6]--[@R9]\]^ Some studies have reported that the use of cSEMS could achieve comparable effects with fewer ERCP procedures.^\[[@R10]--[@R12]\]^ However, because of small sample sizes, the results were not convincing. Thus, we conducted this meta-analysis to compare the effect of cSEMS with MPS on BBS resolution.

2. Methods
==========

2.1. Search strategy
--------------------

We searched for relevant articles published between January 1, 1990 and April 12, 2017. Computerized searches in the PubMed, Embase, and Cochrane library electronic databases were performed by using the terms "benign biliary stricture" or "bile duct stenosis" or "biliary anastomotic strictures" and "plastic stent" and "metal stent" or "metallic stent." Relevant reviews and meta-analyses focusing on BBS treatment were manually examined to identify additional eligible studies.

2.2. Inclusion criteria
-----------------------

Studies meeting the following criteria were included: the enrolled patients had BBS, and strictures resulting from malignant disease were excluded; the study design was a prospective randomized controlled trial (RCT); the study compared the treatment efficacy of plastic stents and cSEMS for BBS, and studies using uncovered SEMS were excluded; and the study should clearly report primary endpoint outcomes, as defined herein.

2.3. Endpoint outcomes defined
------------------------------

The primary endpoint outcome was stricture resolution, and the secondary endpoint outcomes included stricture recurrence, number of ERCP sessions, stent migration, and complications, such as pancreatitis, cholangitis, perforation, hemorrhage, pain, infection, and stent occlusion.

2.4. Data extraction and quality assessment of included studies
---------------------------------------------------------------

Two authors (XZ and XW) independently extracted and recorded data from the studies. The data included the publication year, study period, etiology of stricture, stent design, follow-up time, number of ERCP sessions, success rate, and recurrence rate. Disagreements would be settled through discussion. The risk of bias for RCTs was assessed using the Jadad score.^\[[@R13]\]^

2.5. Ethics approval
--------------------

As all analyses were based on previously published studies, no ethics approval or patient consent was required.

2.6. Statistical analysis
-------------------------

Statistical analyses were performed using Stata 14.0 software. For the analysis of stricture resolution rate, stricture recurrence rate, and stent migration rate, pooled odds ratios (ORs) with 95% confidence intervals (CIs) were used (OR \> 1 favored the MPS group and OR \< 1 favored the cSEMS group). Heterogeneity across studies was evaluated using the I^2^ statistic, an I^2^ \> 50% was regarded as indicating significant heterogeneity and a random-effects model was used; otherwise, a fixed-effects model was used. Potential publication bias was assessed using Egger linear regression test. A *P* value \< .05 indicated statistical significance.

3. Results
==========

3.1. Characteristic of studies included
---------------------------------------

Based on the inclusion and exclusion criteria, 6 RCTs with 330 patients were included in the present meta-analysis (Fig. [1](#F1){ref-type="fig"}).^\[[@R10]--[@R12],[@R14]--[@R16]\]^ The characteristics of included studies are shown in Table [1](#T1){ref-type="table"}. Cochrane bias risk assessment was performed, and the results are shown in Table [2](#T2){ref-type="table"}.

![Search process for trials included in this meta-analysis.](medi-97-e12039-g001){#F1}

###### 

The characteristics of studies included.
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The risk of bias for the studies included.
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3.2. Stricture resolution
-------------------------

All 6 RCTs reported stricture resolution. As shown in Fig. [2](#F2){ref-type="fig"}, the stricture resolution rate in the cSEMS and MPS groups was comparable (OR = 1.05, 95% CI = 0.53--2.07, I^2^ = 29%, *P* = .23, *Z* = 0.13, *P* = .90).

![Meta-analysis of data on stricture resolution in patients with BBS following either cSEMS or MPS treatment. BBS = benign biliary stricture, cSEMS = covered self-expanding metal stent, MPS = multiple plastic stents.](medi-97-e12039-g004){#F2}

Egger test showed no indication of publication bias (2-sided *P* = .887) in stricture resolution rates (Fig. [3](#F3){ref-type="fig"}).

![Egger test of publication bias for stricture resolution rates.](medi-97-e12039-g005){#F3}

3.3. Recurrence rate
--------------------

All 6 RCTs reported stricture recurrence. The recurrence rate was similar in cSEMS and MPS groups (OR = 1.39, 95% CI = 0.69--2.81, I^2^ = 38%, *P* = .17, *Z* = 0.91, *P* = .36) (Fig. [4](#F4){ref-type="fig"}).

![Meta-analysis of data on stricture recurrence rates in patients with BBS following either cSEMS or MPS treatment. BBS = benign biliary stricture, cSEMS = covered self-expanding metal stent, MPS = multiple plastic stents.](medi-97-e12039-g006){#F4}

3.4. ERCP session
-----------------

As shown in Table [1](#T1){ref-type="table"}, there were significantly fewer ERCP sessions in the cSEMS group than in the MPS group. In a study by Martins et al, patients receiving MPS treatment underwent an average of 5 (4--6) ERCP procedures, whereas the cSEMS group underwent an average of 2 sessions until anastomotic biliary stricture resolution (*P* \< .001). Similarly, in a study by Tal et al, the MPS group underwent an average of 4 (3--12) ERCP sessions, while the cSEMS group underwent an average of 2 (*P* \< .001). In a study by Coté et al, fewer ERCP sessions were required to achieve resolution in the cSEMS (2.14) versus MPS group (3.24; mean difference, 1.10; 95% CI = 0.74--1.46; *P* \< .001). A study by Kaffes et al showed similar results (MPS vs cSEMS, 4 \[2--6\] vs 2 \[2--2\], *P* = .001). Thus, the use of cSEMS can decrease the number of ERCP procedures.

3.5. Stent migration
--------------------

Three studies reported the complication of stent migration. Migration was more common in the cSEMS group than in the MPS group. (OR = 1.71, 95% CI = 0.84--3.50, I^2^ = 4%, *P* = .241, *Z* = 1.47, *P* = .14) (Fig. [5](#F5){ref-type="fig"}).

![Meta-analysis of data on stent migration in patients with BBS following either cSEMS or MPS treatment. BBS = benign biliary stricture, cSEMS = covered self-expanding metal stent, MPS = multiple plastic stents.](medi-97-e12039-g007){#F5}

4. Discussion
=============

Numerous studies have evaluated cSEMS as salvage and first-line treatment for BBS. It has been reported that cSEMS were comparable to MPS when used for initial treatment, but achieved resolution with significantly fewer ERCP procedures.^\[[@R10]--[@R12],[@R17]\]^ This meta-analysis further confirms the treatment benefit of cSEMS for BBS.

Stricture recurrence after endoscopic treatment occurs in about 10% to 30% of cases.^\[[@R18]--[@R21]\]^ However, it has been unclear as to which type of stent could decrease the recurrence rate. This meta-analysis showed that the recurrence rate was similar between cSEMS and MPS groups.

Stent migration remains an important limitation of currently available cSEMS.^\[[@R22],[@R23]\]^ However, this study found that the stent migration rate was similar in cSEMS and MPS groups. This is most likely attributable to the improvement of cSEMS with antimigration features. There remains a need to develop novel, expandable stents that can be used in smaller-diameter ducts, without the need for routine follow-up ERCP for retrieval. Similarly, stent migration is also an issue with MPS, because of the sphincterotomy procedure used to facilitate side-by-side stent placement.

Because of lacking of RCTs, the previous meta-analysis was focusing on 1 method (MPS alone or cSEMS alone) in the management of BBS,^\[[@R24],[@R25]\]^ leading to less convincible result. In this meta-analysis, the including studies was all RCTs, resulting in the result more credible.

This meta-analysis had some limitations. First, few RCTs focused on the treatment of BBS using either cSEMS or MPS, limiting the robustness of the meta-analysis. Second, as the etiology of BBS was mixed, subgroup analysis was difficult. Third, the pooled results for stent migration were less valid because of high heterogeneity.

cSEMS were comparable to MPS in achieving stricture resolution in patients with BBS, using fewer ERCP procedures. Further randomized studies are required to improve the treatment of BBS.
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